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Subclinical cardiovascular disease (CVD) is cross-sectionally associated with frailty, but the 
relationship between subclinical CVD and incident frailty has not been reported. We aimed 
to assess this prospective association. 
Design 
Longitudinal analysis of data from the British Regional Heart Study, a prospective cohort 
study. 
Participants 
1057 men, aged 71-92 years, robust or pre-frail at baseline, and without a clinical diagnosis 
of CVD. 
Measurements 
Participants underwent baseline measurement of carotid-femoral pulse wave velocity 
(cfPWV), carotid intima-media thickness (CIMT), carotid distensibility coefficient (DC), and 
ankle-brachial pressure index (ABPI), and had questionnaire-based frailty assessment after 
three years. Frailty status was based on the Fried phenotype. Multivariate logistic 
regressions examined associations between incident frailty and tertile of cfPWV, CIMT, DC, 
and ABPI group (<0.9, 0.9-1.4, 1.4).  
Results 
865 men were examined and completed the 3 year follow-up questionnaire, of whom 78 
became frail. Adjusted for age, prefrailty, body mass index, diabetes, smoking, atrial 
fibrillation, blood pressure, renal function, and incident CVD, higher CIMT was associated 
with greater odds of incident frailty (2nd tertile OR 1.62, 95% CI 0.78-3.35, 3rd tertile OR 2.61, 
95% CI 1.30-5.23, p=0.007, trend p=0.006). cfPWV showed a weaker, non-significant 
association (2nd tertile OR 1.79, 95% CI 0.85-3.78, 3rd tertile OR 1.73, OR 0.81-3.72, p=0.16, 
trend p=0.20). There was no clear association between incident frailty and DC or ABPI. In 
subgroup analyses, CIMT was significantly associated with incident frailty in men 80 years 
(3rd tertile OR 6.99, 95%CI 1.42-34.5), but not in men aged 75-80 or <75 years. 
Conclusion 
Subclinical CVD, as measured by CIMT, is associated with greater risk of incident frailty in 
older men over three year follow-up, independent of the development of clinically-apparent 
stroke, heart failure, or myocardial infarction, and may be a modifiable risk factor for frailty. 
This association may be stronger in very old age. 
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ABPI: ankle-brachial pressure index; cfPWV: carotid-femoral pulse wave velocity; CIMT: 
Carotid intima-media thickness; DC: carotid distensibility coefficient  
Introduction 
 
Frailty, an age-related multisystemic decline in physiological function, reserve, and 
resilience,(1) has a major impact on older individuals’ health, and contributes significantly to 
the global burden of disease.(2) The pathogenesis of frailty is complex and multifactorial. 
Cardiovascular disease (CVD) has been linked with frailty at the epidemiological level and 
may share mechanistic determinants with frailty.(3) In a meta-analysis of 31,343 older 
people, frailty and pre-frailty were associated with greater risk of CVD in both cross-
sectional and longitudinal analyses.(4) A more limited literature suggests the converse 
longitudinal relationship, CVD as a risk factor for the development of frailty, may exist.(5,6) 
 
‘Subclinical’ CVD, detectable via non-invasive imaging modalities, is associated with higher 
mortality risk in older people (7), and has been cross-sectionally associated with frailty and 
aspects of the frailty phenotype(8–16). However, to our knowledge, a longitudinal 
association between subclinical CVD and incident frailty has not yet been described. 
Demonstrating such an association would further support the hypothesis that CVD and 
frailty are closely interrelated and can each lead to one another, and might help risk-stratify 
those at greatest risk of developing frailty as a potential target for intervention. 
 
We therefore aimed to determine, in men without clinical evidence of prevalent CVD, 
prospective associations between subclinical CVD and the development of subsequent 
frailty, based on the Fried phenotype(17). Subclinical CVD was assessed by four methods: 
carotid-femoral pulse wave velocity (cfPWV); carotid intima-media thickness (CIMT); carotid 





All data were obtained within the British Regional Heart Study, a prospective study of 7735 
men, aged 40-59 at enrolment, drawn from 24 British towns and socioeconomically 
representative of those areas. Over 99% of participants were of White European 
ethnicity.(18) Initial screening occurred in 1978-90. A 30-year re-examination took place in 
2010-12, with all 3137 surviving men invited to attend (now aged 71-92). Attendees 
completed a questionnaire, underwent physical examination, and provided a fasting blood 





Attendees of the 30-year examination completed a questionnaire regarding their lifestyle, 
medical, and medication history. Tobacco usage was divided into four categories: never 
smoked, long-term ex-smoker (stopped smoking ≥10 years prior), recent ex-smoker 




The presence of prevalent and incident cardiovascular disease (myocardial infarction, 
stroke, or a diagnosis of ‘heart failure’) was taken from doctor’s diagnoses, based on 
primary care records and validated, where possible, with documentation from secondary 
care. Prevalent diabetes mellitus was defined as either a physician-confirmed diagnosis of 
diabetes mellitus, or a fasting serum glucose of greater than 7mmol/L. Polypharmacy was 




Twelve-lead electrocardiograms were recorded with a Siemens Sicard 460 instrument as 




Blood pressure was measured with an Omron sphygmomanometer twice in the right arm, 
with the subject seated, the arm supported, and an appropriate cuff size used. Subjects 
were seated for approximately two minutes before measurements began. The mean of the 
two readings was used for analysis. With subjects in light clothing and without shoes, height 
was measured with a Harpenden stadiometer to the last complete 0.1 cm, and weight with 
a Tanita MA-418-BC body composition analyser (Tanita, Tokyo, Japan). Body mass index 
(BMI) was calculated as weight/(height)2 (kg/m2). Grip strength was measured using a Jamar 
Hydraulic Hand Dynamometer. Three measurements were taken with each hand, and the 
best of six used for analysis. Walking speed over a 3 metre ‘corridor’ in a smooth-floored 
area was recorded. Chairs were positioned at each end of the corridor, with at least 0.5m 
separation from the ends to allow for acceleration and deceleration effects. Participants 
were asked to walk at their normal walking speed to the second chair, without rushing or 
stopping, and could use their usual walking aids; participants that required assistance from 




Glucose was measured in a fluoride oxidase plasma sample and creatinine measured using 
enzymatic colorimetric assays. Estimated glomerular filtration rate (eGFR) was calculated 
using the MDRD equation. (22) 
 
Non-invasive vascular markers  
Two technicians measured the non-invasive vascular markers in series. Images of the left 
and right carotid arteries were obtained with a 5-10 mHz linear probe using a Zone Ultra 
ultrasound system (Zonare Medical Systems, Mountain View, CA). Longitudinal images of 
the common carotid artery approximately 1 cm proximal to the carotid bifurcation and a 
cross-sectional sweep from the base of the common carotid artery to the mandible were 
recorded.  
 
Using the Carotid Analyser software (Medical Imaging Applications, Iowa City, IA), CIMT 
(distance between the leading edge of the intima and the media-adventitia interface) and 
the peak systolic and end-diastolic common carotid artery diameter were measured. A 5-10 
mm plaque-free area of interest, at least 1cm from the bifurcation, was selected from the 
longitudinal images. A mean CIMT was calculated from individual measurements obtained 
from the three end-diastolic images on each side. 
 
Mean distension was calculated from the maximum and minimum carotid artery diameter 
assessed from three consecutive waveforms. Using these measurements, the distensibility 
coefficient (DC) was measured with the following formula: DC = [(2x mean 
distension/baseline diameter)/mean pulse pressure (kPa)]*1000.(23) 
 
Carotid to femoral pulse wave velocity (cfPWV) was measured using a Vicorder device 
(Skidmore Medical, UK). An inflatable bladder attached to a neck collar was positioned over 
the right carotid pulse, and a Hokanson SC10 cuff was placed around the middle of the right 
thigh. cfPWV length was measured from the sternal notch to the centre of the thigh cuff. 
The cuffs were then simultaneously inflated.  The pressure waveforms were visually 
assessed so that a minimum of 3 good quality waveforms were taken.  Two recordings were 
taken with a difference in cfPWV ≤0.5 m/s and averaged. 
 
Ankle-brachial pressure indices (ABPIs) were measured using a Vicorder device (Skidmore 
Medical, UK), in the right and left sides sequentially. Hokanson SC10 cuffs were positioned 
on the upper arm and lower leg (above the ankle).  Photoplethysmography sensors were 
then clipped to the end of the middle finger and the great toe. Brachial and tibial arteries 
were occluded simultaneously, as the cuffs were inflated to 180mmHg.  As the cuffs slowly 
deflated, the pulse data was visually assessed to minimise artefact from movement and to 
ensure that the blood pressures were taken at the point of the pulse returning at both sites.  
The Vicorder device provided blood pressures for both the brachial and ankle, and the ABPI 
ratio. Optimally, two measurements were recorded with a difference of ≤5 mmHg in either 
the brachial or the ankle pressures, and the mean value used.  If this could not be achieved, 
three measures were taken and averaged. 
 
Reproducibility of the measurements was assessed in two ways: firstly, men from two study 
towns who had attended clinic visits were asked to return for a second visit approximately 
one year later, and the 123 participants who attended underwent repeat measurements 
under the same protocol as the first visit; secondly, both observers repeated an analysis of 
the ultrasound images from the first visit in 109 men to assess inter-observer reproducibility 
of CIMT and carotid distensibility measurement, and repeated their own analyses in 30 men 
to measure intra-observer reliability.(24) 
 
Between-visit reproducibility was acceptable for all measurements (cfPWV coefficient of 
variation [CV]= 5.1%, DC CV= 12%, cIMT CV= 7.8%, ABPI CV= 0.65%), as was intra- and inter-
observer reproducibility of the ultrasound measurements (cIMT inter-observer CV=7.1%, 





Our definition of frailty was based on the Fried phenotype.(17) Five variables were 
calculated from the baseline examination, of which three were based on self-report: 
unintentional weight loss (5% decrease in self-reported weight that respondents felt was 
unintentional); exhaustion (answering ‘no’ to the question ‘Do you feel full of energy?’); low 
physical activity (self-report of being less active or much less active than an average man); 
and two on objective measures: weakness (lowest fifth of grip strength distribution); and 
slow walking speed (lowest fifth of walking speed). Participants who took over 30 seconds 
to complete the 3 meter walk, or who were unable to complete the walk at all, were 
assigned to the ‘slow walking speed’ group. Where measured walking speed was 
unavailable, self-report of low walking pace was used (self-report of walking speed, or being 
unable to walk more than a few steps, or <200 yards, or difficulty walking across a room).  
 
All living men were invited to complete a questionnaire three years later. Unintentional 
weight loss, exhaustion, and low physical activity were calculated in the same way. Slow 
walking speed was based entirely on self-report, as described above. Weakness was defined 
as self-report of ‘fair’ or ‘poor’ grip strength relative to men of the same age. Self-report of 
low gait speed and reduced grip strength have been shown to be associated – individually - 
with greater risk of incident disability and incident falls in this cohort, and a combined frailty 
score based on self-report performs as well as an objectively-measured Fried-based scoring 
system at predicting frailty-related adverse outcomes including incident disability, incident 
falls and mortality. (25) 
 
In all cases, men with three or more features were defined as ‘frail’, those with one or two 




Men with a prior diagnosis of myocardial infarction, stroke, and/or heart failure at baseline 
were excluded, as were those who were frail at baseline. Men who were missing all four 




All analyses were performed using version 9.4 of the SAS System for Windows (Cary, NC, 
USA). Statistical significance was set at p<0.05. Descriptive statistics were used to report 
sample characteristics at baseline in men who did, and did not, develop frailty over the 
follow-up period. Comparisons between these groups were made using t tests for normally 
distributed continuous variables, and the chi-square test for categorical variables. 
 
Given reports of a U-shaped relationship between BMI and frailty,(26) four BMI groups were 
calculated: <20kg/m2; 20-24.9kg/m2; 25-29.9kg/m2, and 30kg/m2, with the 20-24.9kg/m2 
group used as the reference. Three groups were created for ABPI: low (one or both ABPIs 
<0.9), normal (both ABPIs 0.9-1.4), and high (one or both ABPIs 1.4), based on the National 
Institute for Health and Care Excellence (NICE) guidelines, in which an ABPI <0.9 indicates 
possible peripheral arterial disease, and an ABPI 1.4 potential arterial stiffening.(27) 
cfPWV, CIMT, and DC were subdivided into tertiles of each, with the lowest tertile used as 
the reference for cPWV and CIMT, and the highest as reference for DC. 
 
Multivariate logistic regressions were performed, with incident frailty status at follow up 
(frail vs non-frail) as the dichotomous response variable. Separate analyses were conducted 
with cfPWV tertile, CIMT tertile, DC tertile, and ABPI group as categorical explanatory 
variables. These were initially adjusted for age, then for age and frailty status at baseline 
(robust/prefrail), and then for additional potential confounders and/or mediators: BMI 
group, diabetes mellitus, smoking history, atrial fibrillation, use of blood pressure lowering 
medications, incident CVD (i.e. myocardial infarction and/or stroke and/or heart failure) 
between baseline and follow-up (all categorical variables), systolic blood pressure and 
estimated glomerular filtration rate (both continuous variables). To obtain a p value for the 
trend across groups, these analyses were repeated with cPWV/CIMT/DC tertile as ordinal 
explanatory variables. 
 
To investigate for the presence of interactions, age- and pre-frailty-adjusted analyses were 
repeated, incorporating age*[cfPWV/CIMT/DC tertile or ABI group] and prefrailty* 
cfPWV/CIMT/DC tertile or ABI group] interaction terms. Further subgroup analyses 




1722 men (55% of the surviving cohort) attended the baseline examination. 100 men lacked 
complete baseline frailty data and were excluded, as were an additional 303 men who were 
frail at baseline. 260 of the remainder were excluded due to CVD at baseline and a further 2 
men due to missing data on all subclinical CVD parameters. Of the remaining 1057 men, 3-
year follow-up data was available for 865 (82%), on whom the analyses below are based. 55 
of the 192 men with missing follow-up data had died by the time of follow-up. A participant 
flow diagram is given in Fig. 1. 
 
Baseline characteristics and bivariate comparisons 
 
Baseline characteristics of men who did, and did not, develop frailty at 3 year follow-up are 
given in Table 1. Compared to men who did not become frail, men who became frail were 
much more likely to have been pre-frail at baseline and were more likely to have developed 
a myocardial infarction or heart failure by the time of follow-up; they tended to be older 
and have lower diastolic blood pressures.  Men who became frail were more likely to be in 
higher tertiles of cfPWV and CIMT than men who did not become frail, though there was no 





In multivariate analyses (Table 2), when adjusted for age and pre-frailty status, higher CIMT 
was associated with greater odds of incident frailty, compared to those in the first tertile of 
CIMT (2nd tertile OR 1.69, 95% CI 0.85-3.35, p=0.14, 3rd tertile OR 2.70, 95% CI 1.40-5.20, 
p=0.003, trend across groups p=0.002). This was attenuated only slightly on adjustment for 
BMI group, diabetes mellitus, smoking history, atrial fibrillation, use of blood pressure 
lowering medications, incident myocardial infarction, heart failure and/or stroke between 
baseline and follow-up, systolic blood pressure and estimated glomerular filtration rate (2nd 
tertile OR 1.62, 95% CI 0.78-3.35, p=0.20, 3rd tertile OR 2.61, 95% CI 1.30-5.23, p=0.007, 
trend across groups p=0.006). 
 
There were weaker, non-statistically significant associations between higher cfPWV and 
greater odds of incident frailty (2nd tertile OR 1.86, 95% CI 0.92-3.77, p=0.08, 3rd tertile OR 
1.76, 95% CI 0.87-3.57, p=0.12, trend across groups p=0.15), which again weakened slightly 
on further adjustment (2nd tertile OR 1.79, 95% CI 0.85-3.78, p=0.13, 3rd tertile OR 1.73 95% 
CI 0.81-3.72, p=0.16, trend across groups p=0.20). There were no clear associations between 
DC or ABPI and incident frailty. 
 
Interactions 
There was a significant interaction between age, CIMT (tertiles) and incident frailty (formal 
test for interaction p=0.02). No interaction was seen between age and other markers of 
subclinical atherosclerosis (cfPWV/DC/ABPI) with frailty.  No statistically significant 
interaction was seen between prefrailty and markers of subclinical atherosclerosis and 
incident frailty.  
 
The interaction between age and CIMT tertile was further explored by dividing the cohort 
into three age bands at baseline (<75 years, 75-80 years, ≥80 years) and repeating the fully-
adjusted analyses within those groups (Table 3).  There was a strong, statistically-significant 
association between higher CIMT and incident frailty in the ≥80 year group, but not in the 




In a cohort of older British men, higher CIMT was associated with a greater risk of de novo 
frailty three years later, even after adjusting for pre-frailty, other clinical risk factors for CVD 
and frailty, and, importantly, the intervening development of clinically-apparent myocardial 
infarction, heart failure or stroke; this association appeared to be strongest in men aged 80 
or greater. cfPWV showed a weaker, albeit non-statistically-significant, association with 
incident frailty risk, whereas DC and ABPI showed no clear association with the 
development of frailty. 
 
Our findings extend the existing cross-sectional associations previously reported(8–16) by 
demonstrating a longitudinal association between subclinical CVD and incident frailty. To 
our knowledge, this is the first study to do so. Given additional evidence suggesting that 
clinically-apparent CVD is a risk factor for frailty, and vice versa,(28) it seems plausible that 
CVD and frailty share causal mechanisms. Inflammation, or ‘inflammaging’(29) may lead to 
the development of atherosclerosis, CVD and frailty, as might dysfunction of other 
physiological systems, such as haematopoesis and coagulation(30). At the cellular level, 
oxidative stress and cellular senescence occur in both CVD and frailty. Emerging evidence 
suggests that novel biomarkers, such as growth differentiation factor 15, which is secreted 
in response to a wide range of cellular stresses, is associated with frailty in people with CVD, 
and may predict mortality after CVD events.(31) However, our results suggest that, 
whatever the mechanism, subclinical CVD does not lead to frailty solely via the intervening 
development of clinically-apparent cardiovascular disease.  
 
We observed differing relationships between these four measures of subclinical CVD and 
incident frailty, with only CIMT showing a statistically significant positive association. DC, 
cfPWV and ABPI measures have all been associated with frailty features cross-
sectionally(8,15,16), and it is possible that our sample size is too small to detect a 
statistically significant effect, meaning we cannot fully discount longitudinal associations 
with frailty. Arterial stiffness – as reflected by cfPWV and DC – is very closely linked to age 
and to hypertension(32,33), and our adjustments for those factors in multivariate analyses 
may explain the relative lack of association seen between arterial stiffness and incident 
frailty, although our findings are in keeping with other studies that have failed to clearly 
demonstrate an association between hypertension and incident frailty.(34) Furthermore, 
the anatomical site of measurement appeared to show differential associations with frailty: 
CIMT demonstrates structural changes to the wall of the carotid, and ABPI is mostly a 
measure of arterial stenosis in the peripheral arteries of the lower limbs.(35) Atherosclerosis 
of the carotid, and, potentially, cerebral, circulation may be more closely associated with 
incident frailty. 
 
Whilst we accounted for multiple factors in our analyses, it is possible that significant 
unmeasured confounders remain. The intervening development, or presence, at baseline, of 
undiagnosed and/or ‘silent’ CVD is possible and could explain the association seen here. 
“Silent” cerebrovascular infarcts are common, even in healthy elderly people,(36) and have 
separately been associated with frailty(9) and with CIMT (37,38) (although not 
consistently(39,40)); men with higher CIMT may have had a higher silent infarct burden, 
leading to physical frailty. Subclinical cardiac ischaemia or heart failure may also have been 
present, particularly given that there is often a significant delay between symptom onset 
and diagnosis in the latter case.(41) 
 
There was evidence of effect modification within our study, with the association between 
incident frailty and higher CIMT tertile being strongest in men aged 80 or older at baseline. 
Robust over-80s with subclinical atherosclerosis may be at particularly high risk of 
progression to frailty. Stroke risk increases substantially with advancing age(42) and the 
combination of high CIMT and very old age may greatly increase the risk of infarcts, which 
might explain the pattern seen here. Over-80s with low CIMT might also be an unusually 
healthy group, and more likely to achieve ‘successful aging’. Inferences from our subgroup 
analyses must be made with caution, however, given the small number of participants and 
incident frailty events in each subgroup; the estimates of effect size are very wide, and the 
lack of statistically-significant associations in the <75 and 75-80 age groups may be due to 
insufficient statistical power. 
Strengths and limitations 
 
This study presents a novel longitudinal analysis of two important, and common, clinical 
conditions. It benefits from adjustment for multiple potential confounders. However, 
residual confounding may remain, including from factors discussed above. In particular, we 
lacked cardiac imaging (echocardiography or cardiac MRI) or brain imaging (CT/MRI) which 
may have demonstrated damage to those organs at baseline. Approximately 23% of the 
baseline sample was lost to follow-up, which may have introduced selection bias. The 
direction of effect of such bias can only be speculated, but it seems likely that men who 
were frail at follow up would be less able to respond than those in better health, and that 
men who would have been frail might have been more likely to die before follow-up; this 
would have weakened any association seen here. The sample size may have been 
insufficient to allow detection of smaller associations, meaning we cannot fully discount 
associations between DC, ABPI and cfPWV and incident frailty, especially the latter, for 
which a positive but non-statistically significant association was seen. Finally, the cohort 
includes only white European men, and so generalisability to women and other ethnic 
groups is limited. 
 
Implications for future study 
 
These findings should be replicated in other populations. Cardiac and cerebral imaging could 
be used to better stratify participants by demonstrating direct disease burden in those 
organs. Imaging markers of subclinical CVD, such as CIMT, could be investigated for their 
ability to predict frailty and risk-stratify those at highest risk for targeted intervention. 
Treatments for cardiovascular disease and atherosclerosis should be examined for any role 




This study provides evidence of an association between subclinical cardiovascular disease, 
as measured by carotid intima-media thickness, and the development of frailty over a three-
year period, which was independent of incident clinically overt myocardial infarction, stroke 
or heart failure. This association was strongest in men over the age of 80. Imaging markers 
of atherosclerosis at earlier stages showed limited, if any, association with incident frailty. 
Subclinical CVD appears to be a risk factor for frailty. 
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Table 1: Characteristics of study population at baseline and bivariate comparisons. 
 





Age (years) 77.5 (4.1) 79.7 (5.0) <0.001 
Pre-frail at baseline 456 (58%) 72 (92%) <0.001 
Smoking status 
Never smoked 331 (42%) 28 (36%) 0.20 
Recent ex-smoker 403 (51%) 40 (51%) 
Long-term ex-smoker 31 (4%) 5 (6%) 
Current smoker 22 (3%) 5 (6%) 
Comorbidities 
Atrial fibrillation at baseline 47 (6%) 5 (6%) 0.86 
Diabetes mellitus at baseline 103 (13%) 15 (19%) 0.14 
Taking blood pressure lowering drugs 365 (46%) 44 (56%) 0.09 
Estimated glomerular filtration rate 
(mL/min/1.73m2) 
75.4 (15.8) 74.6 (20.1) 0.69 
Developed myocardial infarction between 
baseline and follow up 
6 (1%) 4 (5%) 0.01 
Developed heart failure between baseline and 
follow up 
10 (1%) 4 (5%) <0.001 
Developed stroke between baseline and follow 
up 
9 (1%) 2 (3%) 0.29 
Taking five or more regular medications 222 (28%) 27 (35%) 0.23 
Physical measurements 
Systolic blood pressure (mmHg) 147 (18) 148 (20) 0.57 
Diastolic blood pressure (mmHg) 77.7 (11) 74.9 (12) 0.04 
BMI <20kg/m2 11 (1%) 4 (5%) <0.001 
BMI 20-24.9kg/m2 229 (29%) 20 (26%) 
BMI 25-29.9kg/m2 408 (52%) 38 (49%) 
BMI 30kg/m2 139 (18%) 16 (21%) 
Markers of subclinical atherosclerosis 
1st tertile cfPWV (<9.5m/s) 269 (36%) 13 (19%) 0.02 
2nd tertile cfPWV (9.5-10.8m/s) 241 (32%) 26 (38%) 
3rd tertile cfPWV (10.8m/s) 237 (32%) 29 (43%) 
1st tertile CIMT (<0.73mm) 272 (35%) 14 (18%) 0.002 
2nd tertile CIMT (0.73-0.83mm) 264 (34%) 25 (32%) 
3rd tertile CIMT (0.84mm) 249 (32%) 38 (49%) 
1st tertile DC (<10.4x10-3 kPa) 253 (32%) 30 (38%) 0.53 
2nd tertile DC (10.4-13.6 x10-3 kPa) 262 (34%) 25 (32%) 
3rd tertile DC (13.6 x10-3 kPa) 266 (34%) 23 (29%) 
ABPI <0.8 161 (21%) 20 (28%) 0.19 
ABPI 0.8-1.4 577 (76%) 51 (72%) 
ABPI 1.4 19 (3%) 0 
 
BMI= body mass index, cfPWV= carotid-femoral pulse wave velocity, CIMT= carotid intimal 
media thickness, DC= distensibility coefficient, ABPI= ankle-brachial pressure index 
 
  
Table 2: Associations between subclinical cardiovascular disease and incident frailty in 
multivariate logistic regression analyses.  
 
 
OR= odds ratio, 95% CI = 95% confidence interval 
 Model 1: adjusted for age and frailty status at baseline. Model 2: additionally adjusted for 
BMI group, diabetes mellitus, smoking history, atrial fibrillation, use of blood pressure 
lowering medications, incident myocardial infarction, heart failure and/or stroke between 
baseline and follow-up, systolic blood pressure and estimated glomerular filtration rate. 
1 age-adjusted and Model 1: n=815; Model 2: n=777 
2 age-adjusted and Model 1: n=862; Model 2: n=819 
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0.37  1.27 (0.68-
2.35) 
0.46  
0.8-1.4 1 1 - 1 - 
4 age-adjusted and Model 1: n=828; Model 2: n=789. Numbers for ABPI >1.4 extremely small 
so OR not presented here. 
  








75 years or younger 
(n=267, 16 incident 
frailty cases) 
Between 75 and 80 
years (n=323, 22 
incident frailty cases) 
80 years or older 












































*adjusted for age, pre-frailty, BMI group, diabetes mellitus, smoking history, atrial 
fibrillation, use of blood pressure lowering medications, incident myocardial infarction, 
heart failure and/or stroke between baseline and follow-up, systolic blood pressure and 
estimated glomerular filtration rate. Bold = statistically significant association. 
